R. Gosens (Groningen, Netherlands), M. Proesmans (Leuven, Belgium)
Late Breaking Abstract - Masitinib in severe asthma: Results from a randomized, phase 3 trial
L. Davidescu (Oradea, Romania), P. Chanez (Marseille, France), G. Ursol (Kropyvnytskyi, Ukraine), O. Korzh (Kharkiv, Ukraine), V. Deshmukh (Nagpur, India), L. Kuryk (Kiev, Ukraine), N. Monja-Marie (Brandfort, South Africa), O. Godlevska (Kharkiv, Ukraine), G. Devouassoux (Lyon, France), E. Khodosh (Kharkiv, Ukraine), E. Israel (Boston, United States of America), C. Mansfield (Paris, France), O. Hermine (Paris, France)
|     |
Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE
M. Wechsler (Denver, United States of America), L. Ford (Bellevue, United States of America), J. Maspero (Buenos Aires, Argentina), I. Pavord (Oxford, United Kingdom), Y. Tohda (Osakasayama, Osaka, Japan), D. Langton (Frankston, Australia), C. Domingo (Sabadell, Barcelona, Spain), A. Papi (Ferrara, Italy), A. Bourdin (Montpellier, France), H. Watz (Grosshansdorf, Germany), H. Park (Suwon, Republic of Korea), K. Chapman (Toronto, Canada), X. Mao (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), M. Djandji (Cambridge, United States of America), U. Kapoor (Bridgewater, United States of America), F. Khokhar (Tarrytown, United States of America), L. Mannent (Chilly-Mazarin, France), M. Ruddy (Tarrytown, United States of America), E. Laws (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), M. Hardin (Cambridge, United States of America)
| |
Late Breaking Abstract - LUSTER-1 and -2: randomised controlled trials of fevipiprant in severe asthma
C. Brightling (Leicester (Leicestershire), United Kingdom), M. Gaga (Athens, Greece), H. Inoue (Kagoshima, Japan), J. Li (Guangzhou, China), J. Maspero (Buenos Aries, Argentina), S. Wenzel (Pittsburg, United States of America), S. Maitra (Hyderabad, India), D. Lawrence (Basel, Switzerland), F. Brockhaus (Basel, Sweden), T. Lehmann (Basel, Switzerland), C. Brindicci (Basel, Switzerland), B. Knorr (East Hanover, United States of America), E. Bleecker (Tucson, United States of America)
| |
Wrap-up by discussant and discussion
C. Porsbjerg (Copenhagen, Denmark)
| |
Late Breaking Abstract - Add-on mepolizumab for chronic rhinosinusitis with nasal polyps: SYNAPSE study
C. Hopkins (London, United Kingdom), C. Bachert (Ghent, Belgium), W. Fokkens (Amsterdam, Netherlands), M. Desrosiers (Montreal, Canada), M. Wagenmann (Düsseldorf, Germany), S. Lee (Pittsburgh, United States of America), A. Sousa (Stockley Park, United Kingdom), S. Smith (NC, United States of America), N. Martin (Brentford, United Kingdom), B. Mayer (Stockley Park, United Kingdom), R. Chan (Stockley Park, United Kingdom), J. Han (Norfolk, United States of America)
| |
Effect of controller prescribing according to rs1042713 genotype on asthma related quality of life in young people (PACT): a randomized controlled trial
T. Ruffles (Brighton, United Kingdom), C. Jones (Guildford, United Kingdom), C. Palmer (Dundee, United Kingdom), S. Turner (Aberdeen, United Kingdom), J. Grigg (London, United Kingdom), R. Tavendale (Dundee, United Kingdom), F. Hogarth (Dundee, United Kingdom), P. Rauchhaus (Dundee, United Kingdom), K. Pilvinyte (Dundee, United Kingdom), H. Smith (Brighton, United Kingdom), R. Littleford (Brisbane, Australia), B. Lipworth (Dundee, United Kingdom), S. Mukhopadhyay (Brighton, United Kingdom)
| |
Late Breaking Abstract - Corticosteroid optimisation in severe asthma using composite biomarkers to adjust dose versus a symptom/risk-based algorithm
T. Hardman (Kingston-Upon-Thames, United Kingdom), L. Heaney (Belfast, United Kingdom), J. Busby (Belfast, United Kingdom), C. Hanratty (Belfast, United Kingdom), R. Djukanovic (Southampton, United Kingdom), A. Woodcock (Manchester, United Kingdom), S. Walker (London, United Kingdom), J. Arron (California,, United States of America), D. Choy (California, United States of America), P. Bradding (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom), D. Cowan (Glasgow, United Kingdom), R. Niven (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom), T. Harrison (Nottingham, United Kingdom), P. Howarth (Southampton, United Kingdom), J. Lordan (Newcastle, United Kingdom), A. Mansur (Birmingham, United Kingdom), A. Menzies-Gow (London, United Kingdom), D. Robinson (London, United Kingdom)
| |
Wrap-up by discussant and discussion
M. Gaga (Athens, Greece)
| |